Fine Needle Diathermy and Intraestromal Bevacizumab: A Combined Treatment for Corneal Neovascularization
DOI:
https://doi.org/10.17140/OOJ-1-105Keywords:
Diathermy; Bevacizumab; Corneal neovascularization; New vesselAbstract
Purpose: The cornea is an avascular and transparent tissue due to a high level of anti-angiogenic
molecules. Any alteration of the balance between angiogenic and anti-angiogenic molecules
may cause corneal neovascularization which may lead to reduced visual acuity. Now-a-days
there is a variety of treatments for corneal neovascularization. The aim of the present paper is
to evaluate the efficacy and security of intraestromal bevacizumab combined with fine needle
diathermy on corneal neovascularization.
Method: A 44-year-old patient presented with relapsing corneal ulcer and corneal inferior
neovascularization resistant to conservative treatment, which led us to treat with fine needle
diathermy and intraestromal bevacizumab.
Result: One week after the treatment, some intraestromal hemorrhages still remained but
epitelial edema had solved, observing afterwards a complete resolution of hemorrhages and
angioregression of treated corneal new vessels.
Conclusion: Fine needle diathermy associated with intraestromal bevacizumab should be
considered as a simple, effective and low cost therapeutic option for corneal neovascularization.
References
Gupta D, Illingworth C. Treatments for corneal neovascular-ization: A review. Cornea. 2011; 30(8): 927-938. doi: 10.1097/ ICO.0b013e318201405a
Maddula S, Davis DK, Maddula S, Burrow MK, Ambati BK. Horizons in therapy for corneal angiogenesis. Ophthalmology. 2011; 118(3): 591-599. doi: 10.1016/j.ophtha.2011.01.041
Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT. Corneal neovascularization: An anti-VEGF therapy review. Surv Ophthalmol. 2012; 57(5): 415-429. doi: 10.1016/j. survophthal.2012.01.007
Vieira AC, Höfling-Lima AL, Gomes JÁ, de Freitas D, Farah ME, Belfort R Jr. Intrastromal injection of bevacizumab in patients with corneal neovascularization. Arq Bras Oftalmol. 2012; 75(4): 277-279. doi: 10.1590/S0004-27492012000400012
Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: Fine-needle vessel coagulation combined with anti-VEGFs. Cornea. 2012; 31(8): 887-892. doi: 10.1097/ ICO.0b013e31823f8f7a
Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000; 41(8): 2148-2153. Web site. http://iovs.arvojournals.org/article. aspx?articleid=2123279. Accessed May 29, 2016
Hashemian MN, Zare MA, Rahimi F, Mohammadpour M. Deep intrastromal bevacizumab injection for management of corneal stromal vascularization after deep anterior lamellar keratoplasty, a novel technique. Cornea. 2011; 30(2): 215-218. doi: 10.1097/ICO.0b013e3181e291a6
Yeung SN, Lichtinger A, Kim P, Amiran MD, Slomovic AR. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization. Cornea. 2011; 30(10): 1110-1114. doi: 10.1097/ICO.0b013e31821379aa
Oh JY, Kim MK, Wee WR. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy. Cornea. 2009; 28(9): 1070-1073. doi: 10.1097/ ICO.0b013e31819839f9
Wertheim MS, Cook SD, Knox-Cartwright NE, Van DL, Tole DM. Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy. Cornea. 2007; 26(2): 230-231.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in The Ophthalmology (TOOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
